The extent of ventilator-induced lung injury in mice partly depends on duration of mechanical ventilation

Maria A Hegeman, Sabrine N T Hemmes, Maria T Kuipers, Lieuwe D J Bos, Geartsje Jongsma, Joris J T H Roelofs, Koenraad F van der Sluijs, Nicole P Juffermans, Margreeth B Vroom, Marcus J Schultz, Maria A Hegeman, Sabrine N T Hemmes, Maria T Kuipers, Lieuwe D J Bos, Geartsje Jongsma, Joris J T H Roelofs, Koenraad F van der Sluijs, Nicole P Juffermans, Margreeth B Vroom, Marcus J Schultz

Abstract

Background. Mechanical ventilation (MV) has the potential to initiate ventilator-induced lung injury (VILI). The pathogenesis of VILI has been primarily studied in animal models using more or less injurious ventilator settings. However, we speculate that duration of MV also influences severity and character of VILI. Methods. Sixty-four healthy C57Bl/6 mice were mechanically ventilated for 5 or 12 hours, using lower tidal volumes with positive end-expiratory pressure (PEEP) or higher tidal volumes without PEEP. Fifteen nonventilated mice served as controls. Results. All animals remained hemodynamically stable and survived MV protocols. In both MV groups, PaO2 to FiO2 ratios were lower and alveolar cell counts were higher after 12 hours of MV compared to 5 hours. Alveolar-capillary permeability was increased after 12 hours compared to 5 hours, although differences did not reach statistical significance. Lung levels of inflammatory mediators did not further increase over time. Only in mice ventilated with increased strain, lung compliance declined and wet to dry ratio increased after 12 hours of MV compared to 5 hours. Conclusions. Deleterious effects of MV are partly dependent on its duration. Even lower tidal volumes with PEEP may initiate aspects of VILI after 12 hours of MV.

Figures

Figure 1
Figure 1
Hemodynamic parameters. Systolic blood pressures, heart rates, and peripheral oxygen saturation (SpO2) remained stable throughout 5 hours ((a)–(c)) and 12 hours ((d)–(f)) of mechanical ventilation (MV). Data are presented as median (IQR) of 12–15 ((a)-(b), (d)-(e)), or 3–6 ((c), (f)) mice per group (circle = LVT; square = HVT). LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings.
Figure 2
Figure 2
Respiratory parameters. Lung function is represented by the PaO2 to FiO2 ratio (PaO2/FiO2) (a) and static compliance of the respiratory system (b). The reference (REF) represents the median PaO2/FiO2 from 7 mice ventilated with LVT/PEEP for 30 minutes, that is, 442.4 mmHg (396.2 to 501.0) (a) or the combined static compliance of LVT/PEEP and HVT/ZEEP-ventilated mice at t = 0 h (b). The static compliance did not differ between the two groups at t = 0 h. Data are presented as scatter plot (median) of 11–15 (a) or 4–8 (b) mice per group (triangle = REF; circle = LVT; square = HVT). *Illustrates primary statistical analysis (*P < 0.05, **P < 0.01). NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.
Figure 3
Figure 3
Edema formation. (a): Edema formation is represented by wet to dry ratios of lung tissue (Wet/Dry). Data are presented as scatter plot (median) of 7-8 mice per group (triangle = NVC; circle = LVT; square = HVT). *Illustrates primary statistical analysis (*P < 0.05, **P < 0.01); #illustrates secondary statistical analysis (#P < 0.05). (b) In LVT/PEEP and HVT/ZEEP-ventilated mice, correlation analyses were performed between static compliance of respiratory system and wet/dry of pulmonary tissue. Linear correlations, Pearson correlation coefficients (r), and P values are depicted. NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.
Figure 4
Figure 4
Alveolar-capillary permeability. ((a)-(b)) Alveolar-capillary permeability is represented by total protein and immunoglobulin (Ig)M levels in bronchoalveolar lavage fluid (BALF). (c) Alveolar epithelial type 1 cell injury is represented by receptor for advanced glycation end-products (RAGE) levels in BALF [18]. Data are presented as scatter plot (median) of 7-8 mice per group (triangle = NVC; circle = LVT; square = HVT). *Illustrates primary statistical analysis (*P < 0.05, **P < 0.01); #Illustrates secondary statistical analysis (#P < 0.05, ##P < 0.01). NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.
Figure 5
Figure 5
Cell infiltration. (a) Total cell counts were measured in bronchoalveolar lavage fluid (BALF). ((b)-(c)) Differential cell counts were performed on BALF cytospin preparations to determine neutrophil and macrophage infiltration. Data are presented as scatter plot (median) of 6–8 mice per group (triangle = NVC; circle = LVT; square = HVT). *Illustrates primary statistical analysis (*P < 0.05, **P < 0.01); #illustrates secondary statistical analysis (##P < 0.01). NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.
Figure 6
Figure 6
Inflammatory mediators. ((a)-(b)) Protein levels of the proinflammatory cytokines interleukin (IL)-1β and IL-6 were determined in supernatant of total lung homogenates (HMG). ((c)–(d)) In addition, protein levels of the chemotactic cytokines keratinocyte-derived chemokine (KC) and macrophage inflammatory protein (MIP)-2 were determined. Data are presented as scatter plot (median) of 7-8 mice per group (triangle = NVC; circle = LVT; square = HVT). *Illustrates primary statistical analysis (*P < 0.05, **P < 0.01); #illustrates secondary statistical analysis (#P < 0.05, ##P < 0.01). NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.
Figure 7
Figure 7
Histopathology. Lung sections were stained with hematoxylin eosin (H&E) to analyze lung histopathology (magnification 100x). Total histopathology score was determined by the sum of the score for 4 pathologic parameters: (a) edema, (b) hemorrhage, (c) interstitial cell infiltration, and (d) hyaline membranes. NVC = nonventilated controls; LVT, HVT = LVT/PEEP or HVT/ZEEP ventilator settings; 5 h, 12 h = 5 or 12 hours of ventilation.

References

    1. Malhotra A. Low-tidal-volume ventilation in the acute respiratory distress syndrome. The New England Journal of Medicine. 2007;357(11):1113–1120.
    1. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Annals of Internal Medicine. 2009;151(8):566–576.
    1. Schultz MJ, Haitsma JJ, Slutsky AS, Gajic O. What tidal volumes should be used in patients without acute lung injury? Anesthesiology. 2007;106(6):1226–1231.
    1. Neto AS, Cardoso SO, Manetta JA, et al. Association between use of lung protective ventilation with lower tidal volumes and risk of acute lung injury, mortality, pulmonary infection and atelectasis—a meta-analysis. Journal of the American Medical Association. 2012;308(16):1651–1659.
    1. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. American Journal of Respiratory and Critical Care Medicine. 1998;157(1):294–323.
    1. Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. Journal of Clinical Investigation. 2002;110(11):1703–1716.
    1. Copland IB, Martinez F, Kavanagh BP, et al. High tidal volume ventilation causes different inflammatory responses in newborn versus adult lung. American Journal of Respiratory and Critical Care Medicine. 2004;169(6):739–748.
    1. Haitsma JJ, Uhlig S, Verbrugge SJ, Göggel R, Poelma DLH, Lachmann B. Injurious ventilation strategies cause systemic release of IL-6 and MIP-2 in rats in vivo. Clinical Physiology and Functional Imaging. 2003;23(6):349–353.
    1. Wilson MR, Choudhury S, Goddard ME, O’Dea KP, Nicholson AG, Takata M. High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury. Journal of Applied Physiology. 2003;95(4):1385–1393.
    1. Wilson MR, Choudhury S, Takata M. Pulmonary inflammation induced by high-stretch ventilation is mediated by tumor necrosis factor signaling in mice. American Journal of Physiology. 2005;288(4):L599–L607.
    1. Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J. Inflammatory consequences of lung ischemia-reperfusion injury and low-pressure ventilation. Journal of Surgical Research. 2009;153(2):295–301.
    1. Vaneker M, Halbertsma FJ, van Egmond J, et al. Mechanical ventilation in healthy mice induces reversible pulmonary and systemic cytokine elevation with preserved alveolar integrity: an in vivo model using clinical relevant ventilation settings. Anesthesiology. 2007;107(3):419–426.
    1. Wolthuis EK, Vlaar AP, Choi G, Roelofs JJ, Juffermans NP, Schultz MJ. Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Critical Care. 2009;13(1, article R1)
    1. Mandava S, Kolobow T, Vitale G, et al. Lethal systemic capillary leak syndrome associated with severe ventilator-induced lung injury: an experimental study. Critical Care Medicine. 2003;31(3):885–892.
    1. Tsuno K, Prato P, Kolobow T. Acute lung injury from mechanical ventilation at moderately high airway pressures. Journal of Applied Physiology. 1990;69(3):956–961.
    1. Hegeman MA, Hennus MP, van Meurs M, et al. Angiopoietin-1 treatment reduces inflammation but does not prevent ventilator-induced lung injury. PLoS ONE. 2010;5(12)e15653
    1. Reijmers RM, Groen RWJ, Kuil A, et al. Disruption of heparan sulfate proteoglycan conformation perturbs B-cell maturation and APRIL-mediated plasma cell survival. Blood. 2011;117(23):6162–6171.
    1. Uchida T, Shirasawa M, Ware LB, et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. American Journal of Respiratory and Critical Care Medicine. 2006;173(9):1008–1015.
    1. Gajic O, Dara SI, Mendez JL, et al. Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Critical Care Medicine. 2004;32(9):1817–1824.
    1. Gajic O, Frutos-Vivar F, Esteban A, Hubmayr RD, Anzueto A. Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Medicine. 2005;31(7):922–926.
    1. Determann RM, Royakkers A, Wolthuis EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Critical Care. 2010;14(1, article R1)
    1. Choi G, Wolthuis EK, Bresser P, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105(4):689–695.
    1. Licker M, Diaper J, Villiger Y, et al. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Critical Care. 2009;13(2, article R41)
    1. Michelet P, D’Journo XB, Roch A, et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology. 2006;105(5):911–919.
    1. Wolthuis EK, Choi G, Dessing MC, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents pulmonary inflammation in patients without preexisting lung injury. Anesthesiology. 2008;108(1):46–54.
    1. Zupancich E, Paparella D, Turani F, et al. Mechanical ventilation affects inflammatory mediators in patients undergoing cardiopulmonary bypass for cardiac surgery: a randomized clinical trial. Journal of Thoracic and Cardiovascular Surgery. 2005;130(2):378–383.
    1. Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. Annals of Surgery. 2000;232(2):242–253.
    1. Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Annals of Internal Medicine. 2006;144(8):581–595.
    1. Chaney MA, Nikolov MP, Blakeman BP, Bakhos M. Protective ventilation attenuates postoperative pulmonary dysfunction in patients undergoing cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 2000;14(5):514–518.
    1. Lee PG, Helsmoortel CM, Cohn SM, Fink MP. Are low tidal volumes safe? Chest. 1990;97(2):430–434.
    1. Yang M, Ahn HJ, Kim K, et al. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. 2011;139(3):530–537.
    1. Soutiere SE, Mitzner W. On defining total lung capacity in the mouse. Journal of Applied Physiology. 2004;96(5):1658–1664.
    1. Zosky GR, Janosi TZ, Adamicza A, et al. The bimodal quasi-static and dynamic elastance of the murine lung. Journal of Applied Physiology. 2008;105(2):685–692.
    1. Caironi P, Langer T, Carlesso E, et al. Time to generate ventilator-induced lung injury among mammals with healthy lungs: a unifying hypothesis. Intensive Care Medicine. 2011;37(12):1913–1920.
    1. Lellouche F, Dionne S, Simard S, et al. High tidal volumes in mechanically ventilated patients increase organ dysfunction after cardiac surgery. Anesthesiology. 2012;116(5):1072–1082.
    1. Herold S, Mayer K, Lohmeyer J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Frontiers in Immunology. 2011;2, article 65
    1. Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. American Journal of Physiology. 2004;286(2):L231–L246.

Source: PubMed

3
Subscribe